GlassScriptPhysician profile
Jesse Savage
NPI 1881828085
$93,545.29
in general payments reported to CMS, 2019-2025
12 companies · $454 in 2025
The $454 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $15K · 2021: $19K · 2022: $19K · 2023: $15K · 2024: $49.13 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,120 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,640 · Travel and Lodging: $1,509 · Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,120.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,640.00 |
| Travel and Lodging | $1,509.23 |
| Food and Beverage | $853.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52,029.31 | 2021-2025 | Midas Rex, Stealthstation S8 Platform, Mazor X System |
| Medtronic USA, INC. | $40,280.07 | 2019-2020 | |
| Nexxt Spine LLC | $415.23 | 2021 | |
| Si-Bone, INC. | $356.99 | 2020-2021 | |
| Providence Medical Technology, INC. | $206.62 | 2021-2023 | |
| Integra Lifesciences Corporation | $55.61 | 2024-2025 | Codman Hakim, Codman Certas, Cusa Clarity |
| Baxter Healthcare | $54.04 | 2019 | |
| Neurelis, INC. | $52.99 | 2025 | Valtoco |
| Globus Medical, INC. | $27.80 | 2025 | Senza |
| Depuy Synthes Sales INC. | $27.17 | 2019 | |
| Lilly USA, LLC | $19.92 | 2024 | Emgality |
| Merz Pharmaceuticals, LLC | $19.54 | 2025 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Savage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.